AI assistant
Sending…
TransMedics Group, Inc. — Director's Dealing 2020
Jan 22, 2020
31201_dirs_2020-01-22_cc871ed1-aad6-4d0b-b7fa-7b83dc36c71c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2020-01-17
Reporting Person: Carey John F (VP of Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-01-17 | Common Stock | M | 2000 | $0.28 | Acquired | 3200 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-01-17 | Stock Option (Right to Buy) | $0.28 | M | 2000 | Disposed | 2023-03-27 | Common Stock (2000) | Direct |
Footnotes
F1: The option is fully vested.
More from TransMedics Group, Inc.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 21
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Feb 27
Annual Report
2026
Feb 24
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 20